Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:03 2026-08-07 pm EDT			5-day change	1st Jan Change
267.49 ^USD	+0.75%		+15.04%	+34.09%

Aug. 06	Charles River Laboratories International Insider Sold Shares Worth $1,327,098, According to a Recent SEC Filing	MT
Aug. 06	Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	12.77B		AA
LONZA GROUP AG	49.47B		AAA
REVOLUTION MEDICINES, INC.	43.61B	-	B	-	-
IQVIA HOLDINGS INC.	39.29B		AAA
BEONE MEDICINES AG	39.6B		-
CELLTRION, INC.	32.43B		A
ASCENDIS PHARMA A/S	16.84B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.49B		BBB
EUROFINS SCIENTIFIC SE	14.01B		AA
ICON PUBLIC LIMITED COMPANY	12.69B		AAA
BIO-TECHNE CORPORATION	11.26B		AA
ABIVAX	11.37B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	10.06B	-	B	-	-
APOGEE THERAPEUTICS, INC.	10.12B	-	B	-	-
PHARMARON BEIJING CO., LTD.	11.17B		AA
PROTAGONIST THERAPEUTICS, INC.	9.38B		BB		-
IONIS PHARMACEUTICALS, INC.	9.4B	-	A	-	-
KYMERA THERAPEUTICS, INC.	8.94B	-	BBB	-	-
QIAGEN N.V.	8.75B		AAA
TEMPUS AI, INC.	9.39B		A		-
Average	18.85B		A
Weighted average by Cap.			A